Stem cells treat multiple sclerosis

Treatment with stem cells significantly reduces the degree of disability in patients with multiple sclerosis according to EDSS scale and almost eliminates relapses. These are the results of the second phase of a clinical study conducted in Australia

Multiple sclerosis is a chronic inflammation that damages the nerves of the brain and spinal cord. Immune attack leads to the loss of neuronal protective coating (myelin sheath)

The treatment was performed with own hematopoietic stem cells. Before the introduction of stem cells the patients underwent chemotherapy, aimed at the destruction of hyperactive immune cells that damage nerves. The purpose of the use of stem cells was to restore a healthy immune system

This method of treatment was used in patients who did not respond to conventional therapy with immunosuppressive drugs

The results of this innovative treatment have already been published in the Journal of Neurology, Neurosurgery and Psychiatry. The data from this study are comparable to the results of other centers, treating multiple sclerosis

In Ukraine, the Institute of Cell Therapy has standardized protocols for cryopreservation and cultivation of stem cells for use in clinical practice. In collaboration with specialized state clinics, the Scientific Center of the Institute develops and tests in clinical trials new methods of cell therapy for neurological diseases

The article is based on the material: